cefoperazone has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulos, DA; Chang, EB; Frith, M; Kennedy, M; Koval, JC; Lee, STM; Leone, V; Miyoshi, J; Miyoshi, S; Puertolas, M | 1 |
| Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
2 other study(ies) available for cefoperazone and Colitis
| Article | Year |
|---|---|
Metagenomic Alterations in Gut Microbiota Precede and Predict Onset of Colitis in the IL10 Gene-Deficient Murine Model.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Colitis; Disease Models, Animal; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Interleukin-10; Intestinal Mucosa; Male; Metagenome; Metagenomics; Mice; Mice, Knockout; Prognosis | 2021 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |